Intra-Cellular Therapies (NASDAQ:ITCI) treated its investors to a great month, as shares of the biotech stock shot higher after the company released great clinical news. Get all the details in the following slideshow.
Brian Feroldi has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.